Informatie:
Fout:
ID
44278
Beschrijving
Efficacy and Safety Study of Second-Line Treatment for Hypertension With Autosomal Dominant Polycystic Kidney Disease(ADPKD); ODM derived from: https://clinicaltrials.gov/show/NCT00890279
Link
https://clinicaltrials.gov/show/NCT00890279
Trefwoorden
Versies (2)
- 12-05-18 12-05-18 -
- 20-09-21 20-09-21 -
Houder van rechten
See clinicaltrials.gov
Geüploaded op
20 september 2021
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Kidney, Polycystic, Autosomal Dominant NCT00890279
Eligibility Kidney, Polycystic, Autosomal Dominant NCT00890279
- StudyEvent: Eligibility
Similar models
Eligibility Kidney, Polycystic, Autosomal Dominant NCT00890279
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Polycystic Kidney Disease, Autosomal Dominant
Item
adpkd patients
boolean
C0085413 (UMLS CUI [1])
Blood pressure measurement | Outpatient
Item
blood pressure measured at out-patient setting is above 120/80 mmhg
boolean
C0005824 (UMLS CUI [1])
C0029921 (UMLS CUI [2])
C0029921 (UMLS CUI [2])
Age
Item
age between 20 and 60 years old
boolean
C0001779 (UMLS CUI [1])
Estimated Glomerular Filtration Rate
Item
egfr more than 30 ml/min/1.73m2
boolean
C3811844 (UMLS CUI [1])
Informed Consent
Item
patients give informed consent
boolean
C0021430 (UMLS CUI [1])
Cardiovascular Disease Severe | Liver disease Severe
Item
patients with severe cardiovascular and hepatic disorders
boolean
C0007222 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0023895 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0205082 (UMLS CUI [1,2])
C0023895 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
Central nervous system vascular disorders Complications
Item
patients with complications of central nervous vascular disorders
boolean
C0851452 (UMLS CUI [1,1])
C0009566 (UMLS CUI [1,2])
C0009566 (UMLS CUI [1,2])
Breast Feeding | Childbearing Potential Contraceptive methods Absent
Item
women who are breast feeding and females of childbearing potential who are not using acceptable contraceptive methods
boolean
C0006147 (UMLS CUI [1])
C3831118 (UMLS CUI [2,1])
C0700589 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])
C3831118 (UMLS CUI [2,1])
C0700589 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])
Study Subject Participation Status
Item
patients currently engaging in other experimental protocol
boolean
C2348568 (UMLS CUI [1])
Intracranial Aneurysm
Item
patients with intracranial aneurysma
boolean
C0007766 (UMLS CUI [1])
Patient need for Diuretics
Item
patients who must use diuretics
boolean
C0686904 (UMLS CUI [1,1])
C0012798 (UMLS CUI [1,2])
C0012798 (UMLS CUI [1,2])
Hypersensitivity Candesartan | Hypersensitivity Cilnidipine
Item
allergic patients to candesartan or cilnidipine
boolean
C0020517 (UMLS CUI [1,1])
C0717550 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0378675 (UMLS CUI [2,2])
C0717550 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0378675 (UMLS CUI [2,2])
Hypertensive disease Control | Pharmaceutical Preparations Study Protocol Absent
Item
patients whose hypertension is not controlled by medication of this protocol
boolean
C0020538 (UMLS CUI [1,1])
C0243148 (UMLS CUI [1,2])
C0013227 (UMLS CUI [2,1])
C2348563 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])
C0243148 (UMLS CUI [1,2])
C0013227 (UMLS CUI [2,1])
C2348563 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])